vs

Side-by-side financial comparison of Alector, Inc. (ALEC) and ECB Bancorp, Inc. (ECBK). Click either name above to swap in a different company.

ECB Bancorp, Inc. is the larger business by last-quarter revenue ($9.5M vs $6.2M, roughly 1.5× Alector, Inc.). On growth, ECB Bancorp, Inc. posted the faster year-over-year revenue change (33.8% vs -88.5%). ECB Bancorp, Inc. produced more free cash flow last quarter ($9.0M vs $-184.1M). Over the past eight quarters, ECB Bancorp, Inc.'s revenue compounded faster (23.8% CAGR vs -37.4%).

Alector, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for neurodegenerative diseases. Its product pipeline targets unmet medical needs including Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease, and it collaborates with global pharmaceutical partners to advance candidate therapies through clinical trials.

ECB Bancorp, Inc. (MD) is a US-based bank holding company. It offers a full suite of retail and commercial banking products including deposit accounts, consumer loans, commercial financing and wealth management solutions, primarily serving individuals and small-to-mid enterprises across local markets in Maryland.

ALEC vs ECBK — Head-to-Head

Bigger by revenue
ECBK
ECBK
1.5× larger
ECBK
$9.5M
$6.2M
ALEC
Growing faster (revenue YoY)
ECBK
ECBK
+122.3% gap
ECBK
33.8%
-88.5%
ALEC
More free cash flow
ECBK
ECBK
$193.1M more FCF
ECBK
$9.0M
$-184.1M
ALEC
Faster 2-yr revenue CAGR
ECBK
ECBK
Annualised
ECBK
23.8%
-37.4%
ALEC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALEC
ALEC
ECBK
ECBK
Revenue
$6.2M
$9.5M
Net Profit
$2.6M
Gross Margin
Operating Margin
36.7%
Net Margin
27.3%
Revenue YoY
-88.5%
33.8%
Net Profit YoY
-1696.9%
79.5%
EPS (diluted)
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALEC
ALEC
ECBK
ECBK
Q4 25
$6.2M
$9.5M
Q3 25
$3.3M
$8.8M
Q2 25
$7.9M
$8.0M
Q1 25
$3.7M
$6.9M
Q4 24
$54.2M
$7.1M
Q3 24
$15.3M
$6.6M
Q2 24
$15.1M
$6.3M
Q1 24
$15.9M
$6.2M
Net Profit
ALEC
ALEC
ECBK
ECBK
Q4 25
$2.6M
Q3 25
$-34.7M
$2.4M
Q2 25
$-30.5M
$1.4M
Q1 25
$-40.5M
$1.3M
Q4 24
$-2.1M
$1.4M
Q3 24
$-42.2M
$1.1M
Q2 24
$-38.7M
$791.0K
Q1 24
$-36.1M
$621.0K
Operating Margin
ALEC
ALEC
ECBK
ECBK
Q4 25
36.7%
Q3 25
-1153.6%
37.0%
Q2 25
-433.6%
23.9%
Q1 25
-1216.5%
24.9%
Q4 24
-13.4%
27.3%
Q3 24
-315.7%
23.3%
Q2 24
-302.4%
16.9%
Q1 24
-275.0%
13.4%
Net Margin
ALEC
ALEC
ECBK
ECBK
Q4 25
27.3%
Q3 25
-1063.4%
27.7%
Q2 25
-387.7%
18.0%
Q1 25
-1101.6%
18.7%
Q4 24
-3.8%
20.3%
Q3 24
-275.2%
17.2%
Q2 24
-256.4%
12.6%
Q1 24
-227.0%
10.0%
EPS (diluted)
ALEC
ALEC
ECBK
ECBK
Q4 25
$0.32
Q3 25
$-0.34
$0.29
Q2 25
$-0.30
$0.17
Q1 25
$-0.41
$0.16
Q4 24
$-0.02
$0.18
Q3 24
$-0.43
$0.14
Q2 24
$-0.40
$0.09
Q1 24
$-0.38
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALEC
ALEC
ECBK
ECBK
Cash + ST InvestmentsLiquidity on hand
$256.0M
$82.8M
Total DebtLower is stronger
$10.0M
Stockholders' EquityBook value
$30.6M
$171.9M
Total Assets
$293.2M
$1.6B
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALEC
ALEC
ECBK
ECBK
Q4 25
$256.0M
$82.8M
Q3 25
$291.1M
$201.9M
Q2 25
$307.3M
$191.0M
Q1 25
$354.6M
$143.7M
Q4 24
$413.4M
$309.4M
Q3 24
$457.2M
$114.8M
Q2 24
$503.3M
$108.7M
Q1 24
$562.1M
$109.8M
Total Debt
ALEC
ALEC
ECBK
ECBK
Q4 25
$10.0M
Q3 25
Q2 25
Q1 25
Q4 24
$10.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ALEC
ALEC
ECBK
ECBK
Q4 25
$30.6M
$171.9M
Q3 25
$57.7M
$169.3M
Q2 25
$71.2M
$168.3M
Q1 25
$94.6M
$168.6M
Q4 24
$126.8M
$168.3M
Q3 24
$118.9M
$166.0M
Q2 24
$150.6M
$166.5M
Q1 24
$178.9M
$165.8M
Total Assets
ALEC
ALEC
ECBK
ECBK
Q4 25
$293.2M
$1.6B
Q3 25
$335.3M
$1.6B
Q2 25
$356.4M
$1.5B
Q1 25
$408.3M
$1.5B
Q4 24
$468.3M
$1.4B
Q3 24
$516.0M
$1.4B
Q2 24
$570.7M
$1.3B
Q1 24
$635.5M
$1.3B
Debt / Equity
ALEC
ALEC
ECBK
ECBK
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
0.08×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALEC
ALEC
ECBK
ECBK
Operating Cash FlowLast quarter
$-184.0M
$9.2M
Free Cash FlowOCF − Capex
$-184.1M
$9.0M
FCF MarginFCF / Revenue
-2951.3%
94.7%
Capex IntensityCapex / Revenue
0.7%
2.2%
Cash ConversionOCF / Net Profit
3.55×
TTM Free Cash FlowTrailing 4 quarters
$-326.5M
$14.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALEC
ALEC
ECBK
ECBK
Q4 25
$-184.0M
$9.2M
Q3 25
$-32.5M
$4.0M
Q2 25
$-49.0M
$1.9M
Q1 25
$-60.8M
$-631.0K
Q4 24
$-55.0M
$6.2M
Q3 24
$-50.7M
$861.0K
Q2 24
$-62.8M
$1.4M
Q1 24
$-61.3M
$-429.0K
Free Cash Flow
ALEC
ALEC
ECBK
ECBK
Q4 25
$-184.1M
$9.0M
Q3 25
$-32.5M
$4.0M
Q2 25
$-49.1M
$1.8M
Q1 25
$-60.8M
$-649.0K
Q4 24
$-55.2M
$6.2M
Q3 24
$-50.9M
Q2 24
$-63.1M
$1.3M
Q1 24
$-61.9M
$-449.0K
FCF Margin
ALEC
ALEC
ECBK
ECBK
Q4 25
-2951.3%
94.7%
Q3 25
-997.6%
44.9%
Q2 25
-623.0%
23.0%
Q1 25
-1655.0%
-9.4%
Q4 24
-101.8%
86.8%
Q3 24
-332.1%
Q2 24
-418.6%
21.4%
Q1 24
-389.3%
-7.2%
Capex Intensity
ALEC
ALEC
ECBK
ECBK
Q4 25
0.7%
2.2%
Q3 25
0.3%
0.8%
Q2 25
0.1%
0.6%
Q1 25
0.5%
0.3%
Q4 24
0.3%
0.8%
Q3 24
1.4%
0.0%
Q2 24
2.2%
0.6%
Q1 24
3.4%
0.3%
Cash Conversion
ALEC
ALEC
ECBK
ECBK
Q4 25
3.55×
Q3 25
1.65×
Q2 25
1.32×
Q1 25
-0.49×
Q4 24
4.31×
Q3 24
0.76×
Q2 24
1.75×
Q1 24
-0.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons